Literature DB >> 2267266

The Yale-Brown Obsessive-Compulsive Scale: a reliability and validity study.

S W Kim1, M W Dysken, M Kuskowski.   

Abstract

Twenty-eight nondepressed patients with DSM-III obsessive-compulsive disorder completed both the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and the Leyton Obsessional Inventory (LOI) once a week for a total of three times change. In general, the correlations between the Y-BOCS change scores and the Global Ratings were significantly greater than between the LOI and the Global scores, the Y-BOCS was found to be more reliable than the LOI. Correlations were also obtained for the baseline period between the Y-BOCS and Leyton scores. At the end of a 14-week trial of clomipramine, the Y-BOCS and the LOI were again administered along with a Physician and Patient Global Rating of change. In general, the correlations between the Y-BOCS change scores and the Global Ratings were significantly greater than between the LOI and the Global Ratings. This last finding suggests that the Y-BOCS is a better measure of clinical change than is the LOI.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2267266     DOI: 10.1016/0165-1781(90)90061-9

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  15 in total

1.  Genetic Risk and Outcome of Psychosis (GROUP), a multi-site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods.

Authors:  Nikie Korver; Piotr J Quee; Heleen B M Boos; Claudia J P Simons; Lieuwe de Haan
Journal:  Int J Methods Psychiatr Res       Date:  2012-03-15       Impact factor: 4.035

2.  Development and Psychometric Evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale Second Edition.

Authors:  Eric A Storch; Joseph F McGuire; Monica S Wu; Rebecca Hamblin; Elizabeth McIngvale; Sandra L Cepeda; Sophie C Schneider; Katrina A Rufino; Steven A Rasmussen; Lawrence H Price; Wayne K Goodman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2018-10-25       Impact factor: 8.829

3.  Optimizing Obsessive-Compulsive Symptom Measurement With the Yale-Brown Obsessive-Compulsive Scales-Second Edition.

Authors:  Gregory S Vogt; Michelle Avendaño-Ortega; Sophie C Schneider; Wayne K Goodman; Eric A Storch
Journal:  J Psychiatr Pract       Date:  2022-07-01       Impact factor: 1.841

4.  Anti-Disgust Cognitive Behavioral Therapy for Contamination-Based Obsessive Compulsive Disorder: A Randomized Controlled Clinical Trial.

Authors:  Behzad Salmani; Francesco Mancini; Jafar Hasani; Zahra Zanjani
Journal:  J Clin Med       Date:  2022-05-19       Impact factor: 4.964

5.  The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study.

Authors:  Suck Won Kim; Jon E Grant; Marc N Potenza; Carlos Blanco; Eric Hollander
Journal:  Psychiatry Res       Date:  2009-02-05       Impact factor: 3.222

6.  Cognitive Mediation of Symptom Change in Exposure and Response Prevention for Obsessive-Compulsive Disorder.

Authors:  Yi-Jen Su; Joseph K Carpenter; Laurie J Zandberg; Helen Blair Simpson; Edna B Foa
Journal:  Behav Ther       Date:  2016-03-31

Review 7.  Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD).

Authors:  G M Soomro; D Altman; S Rajagopal; M Oakley-Browne
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

8.  Endophenotypes and serotonergic polymorphisms associated with treatment response in obsessive-compulsive disorder.

Authors:  Fábio M Corregiari; Márcio Bernik; Quirino Cordeiro; Homero Vallada
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

Review 9.  Behavioural and cognitive behavioural therapy for obsessive compulsive disorder (OCD) in individuals with autism spectrum disorder (ASD).

Authors:  Sarah J Elliott; David Marshall; Karen Morley; Eleonora Uphoff; Mrityunjai Kumar; Nicholas Meader
Journal:  Cochrane Database Syst Rev       Date:  2021-09-03

10.  Brain-Derived Neurotrophic Factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis.

Authors:  Sharain Suliman; Sian M J Hemmings; Soraya Seedat
Journal:  Front Integr Neurosci       Date:  2013-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.